S
Scynexis Inc (SCYX)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ
$2.90
-0.31 (-9.66%)
Market Cap: $31.95M
Last updated: Nov 17, 2026 at 11:05 AM ET
Scynexis Inc (SCYX) Valuation Multiples
Scynexis (SCYX) trades at 1.8x sales and 0.6x book value. Its P/B of 0.6x is below its 5-year median of 1.2x. Its forward P/E is 1.9x.
Current Multiples
| Multiple | Value |
|---|---|
| P/E (trailing) | N/A |
| Forward P/E | 1.9x |
| Price to sales | 1.8x |
| Price to book | 0.6x |
| PEG | N/A |
Historical Medians
Against its 10-year medians, its P/B is 72.7% below 2.2x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/B | 0.6x | 1.2x | 2.2x |
Valuation History
Over the 8 of the 10 year ends shown that have a P/S, its P/S ranged from 0.8x in 2023 to 384.4x in 2019.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $5.06 | 9.4x | 1.4x | 0.6x |
| 2024 | $9.68 | N/A | 6.8x | 1.0x |
| 2023 | $17.84 | 1.0x | 0.8x | 1.5x |
| 2022 | $12.48 | N/A | 11.9x | 15.8x |
| 2021 | $48.80 | N/A | N/A | 4.3x |
| 2020 | $61.20 | N/A | N/A | 12.1x |
| 2019 | $72.80 | N/A | 384.4x | 6.9x |
| 2018 | $38.54 | N/A | 80.9x | 0.8x |
| 2017 | $185.60 | N/A | 249.4x | 3.6x |
| 2016 | $255.20 | N/A | 223.3x | 2.3x |
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About SCYX
What is SCYX's forward P/E ratio?
Scynexis has a forward P/E ratio of 1.9x.
Is SCYX stock overvalued?
GNG's valuation label for SCYX is Undervalued.
What is SCYX's price to sales ratio?
Scynexis has a price to sales ratio of 1.8x.
SCYX pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors